Evidence map›Paper›PMID 42569049›Full record

ArticleCureus2026

Direct Immunofluorescence Intensity as a Supportive Marker of Clinical Severity in Pemphigus Vulgaris.

Harshita Reddy Bondugula, Samhitha Mallavalli, Tejaswi Kothapally, Ashok Babu Venna, Sriteja Vemulapalli, Manmohan G, Muralidhar Chinnapaka

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Harshita Reddy BondugulaDepartment of Dermatology, Apollo Institute of Medical Sciences and Research, Hyderabad, IND.
Samhitha MallavalliDeparment of Dermatology, Gandhi Medical College, Secunderabad, IND.
Tejaswi KothapallyDepartment of Dermatology, Apollo Institute of Medical Sciences and Research, Hyderabad, IND.
Ashok Babu VennaDepartment of Dermatology, Patnam Mahender Reddy Institute of Medical Sciences, Hyderabad, IND.
Sriteja VemulapalliDepartment of Dermatology, Skin Veda Clinics, Hyderabad, IND.
Manmohan GDepartment of Dermatology, Apollo Institute of Medical Sciences and Research, Hyderabad, IND.
Muralidhar ChinnapakaDepartment of Pharmacology, Government Medical College and Hospital Maheshwaram, Hyderabad, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Pemphigus vulgaris is an autoimmune blistering disorder in which autoantibody-mediated loss of keratinocyte adhesion leads to mucosal and cutaneous erosions. Direct immunofluorescence (DIF) is routinely used to confirm the diagnosis by demonstrating intercellular IgG deposition, with or without C3, in a fishnet or chicken-wire pattern. Although DIF is primarily a diagnostic test, its staining intensity and immune-reactant pattern may reflect the burden of tissue-bound immune activity. This study assessed the association between DIF findings and clinical severity in patients with pemphigus vulgaris. Materials and methods This prospective observational study included 60 patients with clinically and histopathologically confirmed pemphigus vulgaris. Clinical severity was assessed at presentation using the pemphigus disease area index (PDAI). DIF was performed on perilesional skin or mucosal biopsy specimens using fluorescein-labelled antisera against IgG, IgA, IgM, C3, and fibrinogen. The type, pattern, and intensity of immune deposits were recorded. DIF intensity was graded semi-quantitatively as 0, 1+, 2+, or 3+. The relationship between DIF intensity and PDAI score was analyzed using Spearman's rank correlation coefficient. Associations between DIF findings and severity categories were assessed using the chi-square test or Fisher's exact test, as appropriate. Results The mean age of the patients was 42.6 ± 13.8 years. There were 34 (56.7%) females and 26 (43.3%) males. Mucocutaneous involvement was the most frequent clinical pattern, observed in 38 (63.3%) patients. Based on PDAI grading, 18 (30.0%) patients had mild disease, 26 (43.3%) had moderate disease, and 16 (26.7%) had severe disease. Intercellular IgG deposition was detected in 58 (96.7%) patients, while combined IgG and C3 deposition was observed in 42 (70.0%) patients. Strong DIF staining was seen more often in patients with severe disease. The mean PDAI score increased across DIF grades, from 11.8 ± 4.3 in patients with weak staining to 45.6 ± 12.1 in those with strong staining. DIF intensity showed a moderate positive correlation with PDAI score (Spearman's rho = 0.62, p < 0.001). Combined IgG and C3 deposition was also significantly associated with moderate-to-severe disease (p = 0.004). Conclusion DIF intensity showed a significant positive association with clinical severity in pemphigus vulgaris. Strong intercellular IgG staining and combined IgG-C3 deposition were more frequent among patients with higher PDAI scores. These findings suggest that semi-quantitative DIF reporting may provide useful supportive information at baseline when interpreted together with clinical severity scoring. However, as this study demonstrates association only, DIF intensity should not be considered an independent predictive or prognostic marker without longitudinal validation.

Indexed as

autoimmune blistering diseasec3direct immunofluorescenceiggpemphigus disease area indexpemphigus vulgaris

Identifiers

PMID42569049
PMCPMC13449056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.